Apyx Medical Corporation
APYX
$1.99
-$0.03-1.49%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 20.60% | -33.69% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 20.60% | -33.69% | |||
| Cost of Revenue | 13.94% | -28.39% | |||
| Gross Profit | 25.03% | -36.80% | |||
| SG&A Expenses | 11.64% | -27.38% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 11.75% | -27.73% | |||
| Operating Income | 15.63% | -0.10% | |||
| Income Before Tax | 10.53% | 9.78% | |||
| Income Tax Expenses | 0.00% | -44.94% | |||
| Earnings from Continuing Operations | 10.40% | 10.45% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -281.82% | -29.03% | |||
| Net Income | 8.96% | 10.33% | |||
| EBIT | 15.63% | -0.10% | |||
| EBITDA | 16.17% | -0.24% | |||
| EPS Basic | 8.93% | 15.85% | |||
| Normalized Basic EPS | 8.13% | 15.16% | |||
| EPS Diluted | 8.93% | 15.85% | |||
| Normalized Diluted EPS | 8.13% | 15.16% | |||
| Average Basic Shares Outstanding | 0.00% | 6.58% | |||
| Average Diluted Shares Outstanding | 0.00% | 6.58% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||